Intradermal vaccine delivery: will new delivery systems transform vaccine administration?
about
Intradermal fractional dose vs intramuscular full dose of inactivated polio vaccine for prevention of poliomyelitisTransdermal Drug Delivery: Innovative Pharmaceutical Developments Based on Disruption of the Barrier Properties of the stratum corneum.Dissolving and biodegradable microneedle technologies for transdermal sustained delivery of drug and vaccineTargeted vaccine selection in influenza vaccinationEarly Transcriptional Signatures of the Immune Response to a Live Attenuated Tetravalent Dengue Vaccine Candidate in Non-human PrimatesIntradermal vaccination using the novel microneedle device MicronJet600: Past, present, and futureA rapid immunization strategy with a live-attenuated tetravalent dengue vaccine elicits protective neutralizing antibody responses in non-human primatesNear-infrared laser adjuvant for influenza vaccineEffect of adjuvants on responses to skin immunization by microneedles coated with influenza subunit vaccineLong-term immunogenicity of the influenza vaccine at reduced intradermal and full intramuscular doses among healthy young adultsCutaneous immunization: an evolving paradigm in influenza vaccinesImproving seasonal and pandemic influenza vaccinesMicroneedle-based vaccinesFormulation of microneedles coated with influenza virus-like particle vaccine.Inactivated influenza vaccines: recent progress and implications for the elderly.Laser vaccine adjuvants. History, progress, and potentialMicroneedle and mucosal delivery of influenza vaccines.Transdermal influenza immunization with vaccine-coated microneedle arrays.Host responses in human skin after conventional intradermal injection or microneedle administration of virus-like-particle influenza vaccine.Evaluation of non-inferiority of intradermal versus adjuvanted seasonal influenza vaccine using two serological techniques: a randomised comparative study.Changes in human Langerhans cells following intradermal injection of influenza virus-like particle vaccines.A chimeric alphavirus replicon particle vaccine expressing the hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques from measlesDevelopment of newborn and infant vaccinesHepatitis B vaccine by intradermal route in non responder patients: an update.Laser vaccine adjuvant for cutaneous immunization.Stability kinetics of influenza vaccine coated onto microneedles during drying and storage.Facilitation of transcutaneous drug delivery and vaccine immunization by a safe laser technology.Laser microporation of the skin: prospects for painless application of protective and therapeutic vaccines.Intradermal delivery of vaccines: potential benefits and current challenges.Serological memory and long-term protection to novel H1N1 influenza virus after skin vaccinationTattoo Delivery of a Semliki Forest Virus-Based Vaccine Encoding Human Papillomavirus E6 and E7.Assessment of acceptability and usability of new delivery prototype device for intradermal vaccination in healthy subjects.Immunogenicity of intramuscular MF59-adjuvanted and intradermal administered influenza enhanced vaccines in subjects aged over 60: A literature review.Current evidence on intradermal influenza vaccines administered by Soluvia™ licensed micro injection system.Classification of Laser Vaccine AdjuvantsA randomized clinical trial in adults and newborns in South Africa to compare the safety and immunogenicity of bacille Calmette-Guérin (BCG) vaccine administration via a disposable-syringe jet injector to conventional technique with needle and syrinDose sparing and enhanced immunogenicity of inactivated rotavirus vaccine administered by skin vaccination using a microneedle patch.Semiconductor diode laser device adjuvanting intradermal vaccine.Preclinical evaluation of the immunogenicity and safety of plasmid DNA-based prophylactic vaccines for human cytomegalovirus.Intanza (®) 9 µg intradermal seasonal influenza vaccine for adults 18 to 59 years of age.
P2860
Q24187419-2C1E4FA6-7AE3-4120-8B55-D86C50EF6E94Q26778469-A089EDAC-CDF7-46B6-B446-33F2862FEC4AQ27013822-CC612298-CD8B-424E-A41F-9FD0ECED424AQ27030899-7346A75D-9C7A-41EB-A042-A34DAF75F9EFQ27303669-E7F06D55-96DE-4002-A8DF-1E5AE26EB7F4Q28087074-D35AAF71-BB5A-4E76-8A18-C7E9F4B32864Q28241909-B7BA5D1E-C8BB-4549-9F6B-ACF205FFE8D8Q28536886-0DB4128F-3C90-4A24-A5F5-FFA8CF8D8595Q28728791-9143CD41-7A30-4614-93D6-30B8E0764CBDQ30352137-72ADEBBA-0ED6-49D6-BEFC-6368E32AD564Q30358895-BF28CB3C-2784-4F63-84AB-35167CDB55D3Q30377211-B6F336C2-43FD-4418-8C9A-9269264524E0Q30380910-0F4BB515-D1BF-4285-95E8-81DCF62E604CQ30392132-73A738D4-1CA2-48D6-996F-EA85DE805059Q30399057-F0262C42-1F43-4695-8763-6CFABF262304Q30413501-9EB74050-2614-4A29-A7EF-4C7E1952C2BDQ30418015-ADA74F55-31C5-4D17-BAF5-1AAA7AE9208CQ33416417-04F98693-2F08-4420-A650-3994DE445A32Q33563977-9F891285-44E6-4C64-816E-0DA511CD807CQ33588044-18D910CF-AD42-4D5C-8AFD-C605AF016787Q33682225-A402279A-C360-46A8-B0DA-5B90F8F0A84AQ33769306-442F58C6-CAFE-4275-A7B4-C5A8A7999DD9Q33941914-BBB8B4CE-5AC7-45C0-A3D3-6938362207CFQ34036643-19D69F20-5CA3-4F53-9F74-7064D0E22EA6Q34046148-21C69F8A-3719-4808-9245-C5992EBD5AEFQ34047875-5481CCB4-E4D2-4BD8-A3DD-3AEA89F0DC5EQ34133549-161A5448-5740-4A30-80CD-24ACB1A59127Q34593082-D1AE60DD-34BD-4D4C-9D3A-1A6A1C2B9031Q34601669-A16B8A45-8A40-4A8C-9FA5-F06A6B2039B3Q35129385-000AE5E7-C61B-4C5B-8F1D-E40801AF14D4Q35826994-31540CA3-40F8-492C-8C86-7C4B44127AFEQ35886486-F062EA3C-5834-41F0-AAF3-8375F8F9425DQ35887679-DCF115A0-692F-4F52-BF91-D99864A968DEQ35952784-B6538D11-EE85-4A3E-AFC5-42A9BDF4D716Q35996738-7FE50B59-DF45-418B-92D5-8B7C55F5F24FQ36041609-9EFC7E7C-1463-48F8-B1C0-71E49030B1DDQ36175711-F2B9FE8B-D779-42C2-B7E2-D24A0FAAD867Q36330880-41A62631-F98E-437A-B3E8-3C5EAC4B6F2FQ36694825-828FD160-0DC2-45CB-AFE0-3804C35E4E02Q36887912-23A5B5C0-30C1-4B7F-9FC0-9F086258981E
P2860
Intradermal vaccine delivery: will new delivery systems transform vaccine administration?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 22 April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Intradermal vaccine delivery: will new delivery systems transform vaccine administration?
@en
Intradermal vaccine delivery: will new delivery systems transform vaccine administration?
@nl
type
label
Intradermal vaccine delivery: will new delivery systems transform vaccine administration?
@en
Intradermal vaccine delivery: will new delivery systems transform vaccine administration?
@nl
prefLabel
Intradermal vaccine delivery: will new delivery systems transform vaccine administration?
@en
Intradermal vaccine delivery: will new delivery systems transform vaccine administration?
@nl
P1433
P1476
Intradermal vaccine delivery: will new delivery systems transform vaccine administration?
@en
P2093
Paul Henri Lambert
Philippe E Laurent
P304
P356
10.1016/J.VACCINE.2008.03.095
P407
P577
2008-04-22T00:00:00Z